Treatment Trials

2 Clinical Trials for Various Conditions

Focus your search

      COMPLETED
      A Study With SAGE-547 for Super-Refractory Status Epilepticus
      Description

      This is a randomized, double-blind, placebo-controlled trial, designed to evaluate the efficacy and safety of SAGE-547 administered as a continuous intravenous infusion to subjects in Super-Refractory Status Epilepticus (SRSE).

      Conditions
      Super-Refractory Status Epilepticus
      Talk to us
      COMPLETED
      Study to Evaluate SAGE-547 Injection as Adjunctive Therapy for the Treatment of Super-Refractory Status Epilepticus
      Description

      The purpose of this study is to evaluate the safety and tolerability of SAGE-547 in participants in super-refractory status epilepticus (SRSE).

      Conditions
      Super-refractory Status Epilepticus
      Talk to us